查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2026804

毒性測試市場預測至2034年—按產品類型、測試類型、方法論、技術、最終用戶和地區分類的全球分析

Toxicology Testing Market Forecasts to 2034 - Global Analysis By Product, Test Type, Method, Technology, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球毒性測試市場規模將達到 180.511 億美元，在預測期內以 9.7% 的複合年成長率成長，到 2034 年將達到 378.579 億美元。

毒性測試評估物質對生物體的影響，並確定其對人類健康和環境的潛在風險。這有助於識別化學物質、藥品、消費品和環境污染物的安全性、毒性和相關風險。其重要性在於透過識別和降低風險來保護公眾健康，支持法規遵循，並指南產品開發。

根據美國國家生物技術資訊中心 (NCBI) 的數據，在藥物發現階段合成的 10,000 種化合物中，只有 250 種能進入臨床前階段，最終只有一種藥物能獲得美國食品藥物管理局 (FDA) 的核准。

擴大研發活動

製藥、生物技術和化學製造等行業不斷探索新的化合物、配方和產品。毒性測試在這些領域中發揮著至關重要的作用，它評估這些創新技術在上市前的安全性、有效性和潛在風險。此外，嚴格的毒性評估有助於確保符合監管標準，並減輕對人類健康和環境的不利影響。隨著研發活動活性化以滿足不斷變化的消費者需求和技術突破，對全面毒性測試的需求日益成長，使其成為新藥、化學品和產品研發和核准中必不可少的步驟。

數據解讀的複雜性

眾多實驗和最尖端科技產生的複雜多樣的數據為分析帶來了挑戰，難以將其轉化為有用的見解。準確評估這種複雜性需要專業知識、先進設備和標準化框架。對這些複雜統計數據的解讀誤差和不確定性會阻礙風險評估、監管申報和產品開發決策，並可能導致市場核准和開發延誤。

對替代檢測方法的需求日益成長

體外檢測、類器官、微流體系統和計算模型等先進技術為毒性評估提供了極具前景的替代方案，能夠提供更準確、更經濟高效且更符合倫理的測試方法。投資研發以檢驗和商業化這些替代方案的公司將能夠充分利用這一日益成長的市場需求。此外，這些替代方案的廣泛應用圖簡化測試流程，加快結果回饋，並符合全球範圍內更人性化和預測性毒性評估的趨勢。因此，市場擴張正在加速。

法規變更

安全評估相關法規的不斷演變和日益嚴格要求企業持續調整和遵守，這影響著調查方法、檢驗要求和產品核可流程。監管標準的快速變化和新指南的推出可能導致不確定性增加、成本上升和核准流程延誤。未能及時回應新標準可能導致違規、競爭力下降和市場准入壁壘，給毒性測試市場的企業帶來挑戰，使其難以維持效率並滿足不斷變化的要求。

新冠疫情的影響

新冠疫情初期，封鎖措施對營運和研發造成了衝擊，資源轉移到與疫情相關的調查中。這導致臨床試驗和監管流程延誤，產品核准速度放緩。然而，這場危機凸顯並強化了毒性測試在疫苗研發和藥物安全性評估中的重要性。業界迅速適應遠距辦公和虛擬測試，加速了創新和數位化進程。對安全性評估的日益重視促使人們重新關注嚴謹的調查方法，為疫情後穩健的復甦奠定了基礎。

在預測期內，基因毒性測試領域預計將是規模最大的領域。

遺傳毒性測試領域預計將佔據最大佔有率。遺傳毒性測試利用各種檢測方法來評估物質誘發突變、染色體異常或DNA損傷的能力。這對於識別潛在的致癌性和有害化合物至關重要。這些測試包括體外和體內方法，例如Ames試驗、微核試驗和彗星試驗，從而提供全面的遺傳毒性分析。此外，了解遺傳毒性有助於確定藥物、化學物質、農藥和消費品的安全性，從而顯著促進監管評估，並確保人類健康和環境免受有害基因改變的侵害。

在預測期內，體內試驗領域預計將呈現最高的複合年成長率。

預計在預測期內，體內試驗領域將迎來顯著成長。體內試驗是指利用完整的活體生物（例如植物和動物）進行的實驗。這有助於識別毒性水平、不良反應和潛在的健康風險，為監管和安全評估提供關鍵數據。此外，儘管涉及倫理考量，但這些試驗對於全面了解物質的生物效應以及保護人類健康和環境免受潛在有害化合物的侵害至關重要。

市佔率最大的地區：

由於亞太地區的工業化程度高、嚴格監管以及環境安全意識不斷增強，該地區在預測期內佔據了最大的市場佔有率。技術進步、醫藥和生物技術產業的擴張，以及化妝品和食品產業對毒性評估的需求，都在推動市場成長。此外，中國、印度、日本和韓國等國家憑藉其經濟擴張和活性化的研發活動，也為市場成長做出了顯著貢獻。市場成長的驅動力在於對產品安全評估日益重視以及對可靠毒性測試方法的需求。

複合年成長率最高的地區：

由於北美地區擁有嚴格的法規結構、日益重視產品安全以及技術進步，預計該地區在預測期內將實現盈利成長。該地區成熟的製藥和生物技術產業，以及活性化的研發活動，正在推動市場擴張。此外，人們對化學品暴露的日益關注，以及包括醫療保健、化妝品和環境監測在內的各個領域對高效毒性評估的需求，也促進了市場成長。美國和加拿大等主要國家在調查方法不斷進步，從而促進了創新和市場滲透。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章 全球毒理學檢測市場：依產品分類

  • 裝置
  • 試劑和試劑盒
  • 其他產品

第6章 全球毒理學檢測市場：依檢測類型分類

  • 基因毒性測試
  • 致癌性試驗
  • 發育和生殖毒性試驗
  • 其他測試類型

第7章 全球毒理學檢測市場：依檢測方法分類

  • 生化試驗
  • 驗血
  • 病理檢查

第8章 全球毒理學檢測市場：依技術分類

  • 體內試驗
  • 體外試驗

第9章 全球毒理學檢測市場：依最終用戶分類

  • 食品飲料業
  • 製藥和生物技術公司
  • 化妝品和個人護理行業
  • 學術和研究機構
  • 其他最終用戶

第10章 全球毒理學檢測市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第11章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第12章：公司簡介

  • Abbott Laboratories
  • Eurofins Scientific
  • Laboratory Corporation Of America Holdings
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • Agilent Technolgies, Inc.
  • Catalent, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bioivt
  • Gentronix
Product Code: SMRC24561

According to Stratistics MRC, the Global Toxicology Testing Market is accounted for $18051.1 million in 2026 and is expected to reach $37857.9 million by 2034 growing at a CAGR of 9.7% during the forecast period. Toxicology testing involves evaluating the effects of substances on living organisms to assess potential hazards to human health and the environment. It determines the safety, toxicity, and risks associated with chemicals, pharmaceuticals, consumer products, and environmental pollutants. Its importance lies in safeguarding public health by identifying and mitigating risks, aiding regulatory compliance, and guiding product development.

According to NCBI, for every 10,000 compounds synthesized in the discovery phase, only 250 reach the preclinical phase, ultimately resulting in one approved drug by the FDA.

Market Dynamics:

Driver:

Increasing R&D activities

Industries such as pharmaceuticals, biotechnology, and chemical manufacturing are continually exploring novel compounds, formulations, and products. Toxicology testing plays a pivotal role in these sectors by evaluating the safety, efficacy, and potential risks of these innovations before market introduction. Moreover, robust toxicological assessments ensure compliance with regulatory standards and help mitigate adverse effects on human health and the environment. The need for thorough toxicological testing is growing as R&D efforts to address changing consumer demands and technological breakthroughs rise, making it an essential step in the creation and approval of novel medications, chemicals, and products.

Restraint:

Complexity in data interpretation

The complex and varied data produced by many experiments and cutting-edge technologies presents analytical difficulties that make it difficult to analyze and translate into useful insights. Accurate assessment of this complexity necessitates specific knowledge, advanced instruments, and standardized frameworks. Errors or uncertainty when interpreting these complex statistics can impair decision-making in risk assessments, regulatory filings, and product development, thereby impeding market approvals and developments.

Opportunity:

Growing demand for alternative testing methods

Advanced technologies such as in vitro assays, organoids, microfluidics systems, and computational models offer promising alternatives for toxicology assessments, providing more accurate, cost-effective, and ethical testing avenues. Companies investing in research and development to validate and commercialize these alternative methods stand to capitalize on this growing demand. Moreover, the widespread adoption of these alternatives also streamlines testing processes, fosters quicker results, and aligns with the global trend towards more humane and predictive toxicology evaluations. Thus, there is propelling market expansion.

Threat:

Regulatory changes

Evolving and stringent regulations governing safety assessments necessitate continuous adaptation and compliance, impacting testing methodologies, validation requirements, and timelines for product approvals. Sudden shifts in regulatory standards or the introduction of new guidelines may lead to uncertainties, increased costs, and delays in the approval process. Failure to promptly align with new standards could result in non-compliance penalties, reduced competitiveness, and impediments to market access, posing challenges for companies in maintaining efficiency and meeting evolving requirements within the toxicology testing market.

Covid-19 Impact

The COVID-19 outbreak initially affected operations and research due to lockdowns and redirected resources towards pandemic-related studies. Delays in trials and regulatory processes ensued, slowing down product approvals. However, the crisis highlighted the criticality of toxicology testing in vaccine development and drug safety assessments, elevating its importance. The industry adapted with remote work and virtual trials, fostering innovation and digitalization. Increased awareness of safety evaluations resulted in a renewed emphasis on robust testing methodologies, paving the way for a resilient recovery post-pandemic.

The genetic toxicology testing segment is expected to be the largest during the forecast period

The genetic toxicology testing segment is estimated to hold the largest share. Genetic toxicology testing employs assays to evaluate a substance's ability to induce mutations, chromosomal aberrations, or DNA damage, which is crucial in identifying potential carcinogens or harmful compounds. These tests encompass in vitro and in vivo methods, such as the Ames test, micronucleus assay, and comet assay, to comprehensively analyze genotoxicity. Moreover, understanding genetic toxicity aids in determining the safety of pharmaceuticals, chemicals, pesticides, and consumer products, contributing significantly to regulatory evaluations, and ensuring the protection of human health and the environment from harmful genetic alterations.

The in-vivo testing segment is expected to have the highest CAGR during the forecast period

The in-vivo testing segment is anticipated to have lucrative growth during the forecast period. In vivo tests refer to a type of experiment that is carried out within a whole, living organism, such as a plant or animal. It helps to determine toxicity levels, adverse reactions, and potential health hazards, providing crucial data for regulatory assessments and safety evaluations. Moreover, these tests, despite ethical considerations, remain essential for comprehensively understanding the biological effects of substances and ensuring the protection of human health and the environment from potentially harmful compounds.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to increasing industrialization, stringent regulatory guidelines, and rising awareness regarding environmental safety. Advancements in technology and expanding pharmaceutical and biotechnology sectors, coupled with the demand for toxicological evaluations in the cosmetics and food industries, drive market expansion. Moreover, countries like China, India, Japan, and South Korea are pivotal contributors due to their expanding economies and growing research initiatives. This market's growth is fuelled by the emphasis on product safety assessment and the need for reliable toxicology testing methods.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period, due to stringent regulatory frameworks, heightened focus on product safety, and technological advancements. The region's well-established pharmaceutical and biotechnology industries, along with increased R&D activities, propel market expansion. Moreover, rising concerns about chemical exposure, coupled with the need for efficient toxicological evaluations in various sectors, including healthcare, cosmetics, and environmental monitoring, are driving market growth. Key contributors like the United States and Canada witness continual advancements in testing methodologies, fostering innovation and market penetration.

Key players in the market

Some of the key players in the Toxicology Testing Market include Abbott Laboratories, Eurofins Scientific, Laboratory Corporation Of America Holdings, Thermo Fisher Scientific, Inc., Danaher Corporation, Agilent Technolgies, Inc., Catalent, Inc., Bio-Rad Laboratories, Inc., Bioivt and Gentronix.

Key Developments:

In November 2023, Thermo Fisher Scientific & Flagship Pioneering Expand Ongoing Strategic Partnership to Jointly Create New Platform Companies with First-in-Class Enabling Technologies for Life Sciences.

In October 2023, Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific(TM) Meridian(TM) EX System- an electron-beam-based failure analysis solution designed to enable precise fault localization on advanced semiconductor logic technologies.

In September 2023, Thermo Fisher Scientific and National Minority Quality Forum Collaborate to support biopharmaceutical and biotech customers in meeting regulatory expectations to enroll and retain patients in clinical trials who more fully reflect real-world populations experiencing the disease or health condition being studied, including U.S. Food and Drug Administration requirements around diversity action plans.

Products Covered:

  • Instruments
  • Reagents and Kits
  • Other Products

Test Types Covered:

  • Genetic Toxicology Testing
  • Carcinogenicity Testing
  • Developmental and Reproductive Toxicology Testing
  • Other Test Types

Methods Covered:

  • Biochemical Testing
  • Hematology Testing
  • Pathology Testing

Technologies Covered:

  • In-vivo Testing
  • In-vitro Testing

End Users Covered:

  • Food and Beverage Industry
  • Pharmaceutical and Biotechnology Companies
  • Cosmetics and Personal Care Industry
  • Academic and Research Institutions
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Toxicology Testing Market, By Product

  • 5.1 Introduction
  • 5.2 Instruments
  • 5.3 Reagents and Kits
  • 5.4 Other Products

6 Global Toxicology Testing Market, By Test Type

  • 6.1 Introduction
  • 6.2 Genetic Toxicology Testing
  • 6.3 Carcinogenicity Testing
  • 6.4 Developmental and Reproductive Toxicology Testing
  • 6.5 Other Test Types

7 Global Toxicology Testing Market, By Method

  • 7.1 Introduction
  • 7.2 Biochemical Testing
  • 7.3 Hematology Testing
  • 7.4 Pathology Testing

8 Global Toxicology Testing Market, By Technology

  • 8.1 Introduction
  • 8.2 In-vivo Testing
  • 8.3 In-vitro Testing

9 Global Toxicology Testing Market, By End User

  • 9.1 Introduction
  • 9.2 Food and Beverage Industry
  • 9.3 Pharmaceutical and Biotechnology Companies
  • 9.4 Cosmetics and Personal Care Industry
  • 9.5 Academic and Research Institutions
  • 9.6 Other End Users

10 Global Toxicology Testing Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Abbott Laboratories
  • 12.2 Eurofins Scientific
  • 12.3 Laboratory Corporation Of America Holdings
  • 12.4 Thermo Fisher Scientific, Inc.
  • 12.5 Danaher Corporation
  • 12.6 Agilent Technolgies, Inc.
  • 12.7 Catalent, Inc.
  • 12.8 Bio-Rad Laboratories, Inc.
  • 12.9 Bioivt
  • 12.10 Gentronix

List of Tables

  • Table 1 Global Toxicology Testing Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Toxicology Testing Market Outlook, By Product (2023-2034) ($MN)
  • Table 3 Global Toxicology Testing Market Outlook, By Instruments (2023-2034) ($MN)
  • Table 4 Global Toxicology Testing Market Outlook, By Reagents and Kits (2023-2034) ($MN)
  • Table 5 Global Toxicology Testing Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 6 Global Toxicology Testing Market Outlook, By Test Type (2023-2034) ($MN)
  • Table 7 Global Toxicology Testing Market Outlook, By Genetic Toxicology Testing (2023-2034) ($MN)
  • Table 8 Global Toxicology Testing Market Outlook, By Carcinogenicity Testing (2023-2034) ($MN)
  • Table 9 Global Toxicology Testing Market Outlook, By Developmental and Reproductive Toxicology Testing (2023-2034) ($MN)
  • Table 10 Global Toxicology Testing Market Outlook, By Other Test Types (2023-2034) ($MN)
  • Table 11 Global Toxicology Testing Market Outlook, By Method (2023-2034) ($MN)
  • Table 12 Global Toxicology Testing Market Outlook, By Biochemical Testing (2023-2034) ($MN)
  • Table 13 Global Toxicology Testing Market Outlook, By Hematology Testing (2023-2034) ($MN)
  • Table 14 Global Toxicology Testing Market Outlook, By Pathology Testing (2023-2034) ($MN)
  • Table 15 Global Toxicology Testing Market Outlook, By Technology (2023-2034) ($MN)
  • Table 16 Global Toxicology Testing Market Outlook, By In-vivo Testing (2023-2034) ($MN)
  • Table 17 Global Toxicology Testing Market Outlook, By In-vitro Testing (2023-2034) ($MN)
  • Table 18 Global Toxicology Testing Market Outlook, By End User (2023-2034) ($MN)
  • Table 19 Global Toxicology Testing Market Outlook, By Food and Beverage Industry (2023-2034) ($MN)
  • Table 20 Global Toxicology Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2023-2034) ($MN)
  • Table 21 Global Toxicology Testing Market Outlook, By Cosmetics and Personal Care Industry (2023-2034) ($MN)
  • Table 22 Global Toxicology Testing Market Outlook, By Academic and Research Institutions (2023-2034) ($MN)
  • Table 23 Global Toxicology Testing Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 24 North America Toxicology Testing Market Outlook, By Country (2023-2034) ($MN)
  • Table 25 North America Toxicology Testing Market Outlook, By Product (2023-2034) ($MN)
  • Table 26 North America Toxicology Testing Market Outlook, By Instruments (2023-2034) ($MN)
  • Table 27 North America Toxicology Testing Market Outlook, By Reagents and Kits (2023-2034) ($MN)
  • Table 28 North America Toxicology Testing Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 29 North America Toxicology Testing Market Outlook, By Test Type (2023-2034) ($MN)
  • Table 30 North America Toxicology Testing Market Outlook, By Genetic Toxicology Testing (2023-2034) ($MN)
  • Table 31 North America Toxicology Testing Market Outlook, By Carcinogenicity Testing (2023-2034) ($MN)
  • Table 32 North America Toxicology Testing Market Outlook, By Developmental and Reproductive Toxicology Testing (2023-2034) ($MN)
  • Table 33 North America Toxicology Testing Market Outlook, By Other Test Types (2023-2034) ($MN)
  • Table 34 North America Toxicology Testing Market Outlook, By Method (2023-2034) ($MN)
  • Table 35 North America Toxicology Testing Market Outlook, By Biochemical Testing (2023-2034) ($MN)
  • Table 36 North America Toxicology Testing Market Outlook, By Hematology Testing (2023-2034) ($MN)
  • Table 37 North America Toxicology Testing Market Outlook, By Pathology Testing (2023-2034) ($MN)
  • Table 38 North America Toxicology Testing Market Outlook, By Technology (2023-2034) ($MN)
  • Table 39 North America Toxicology Testing Market Outlook, By In-vivo Testing (2023-2034) ($MN)
  • Table 40 North America Toxicology Testing Market Outlook, By In-vitro Testing (2023-2034) ($MN)
  • Table 41 North America Toxicology Testing Market Outlook, By End User (2023-2034) ($MN)
  • Table 42 North America Toxicology Testing Market Outlook, By Food and Beverage Industry (2023-2034) ($MN)
  • Table 43 North America Toxicology Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2023-2034) ($MN)
  • Table 44 North America Toxicology Testing Market Outlook, By Cosmetics and Personal Care Industry (2023-2034) ($MN)
  • Table 45 North America Toxicology Testing Market Outlook, By Academic and Research Institutions (2023-2034) ($MN)
  • Table 46 North America Toxicology Testing Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 47 Europe Toxicology Testing Market Outlook, By Country (2023-2034) ($MN)
  • Table 48 Europe Toxicology Testing Market Outlook, By Product (2023-2034) ($MN)
  • Table 49 Europe Toxicology Testing Market Outlook, By Instruments (2023-2034) ($MN)
  • Table 50 Europe Toxicology Testing Market Outlook, By Reagents and Kits (2023-2034) ($MN)
  • Table 51 Europe Toxicology Testing Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 52 Europe Toxicology Testing Market Outlook, By Test Type (2023-2034) ($MN)
  • Table 53 Europe Toxicology Testing Market Outlook, By Genetic Toxicology Testing (2023-2034) ($MN)
  • Table 54 Europe Toxicology Testing Market Outlook, By Carcinogenicity Testing (2023-2034) ($MN)
  • Table 55 Europe Toxicology Testing Market Outlook, By Developmental and Reproductive Toxicology Testing (2023-2034) ($MN)
  • Table 56 Europe Toxicology Testing Market Outlook, By Other Test Types (2023-2034) ($MN)
  • Table 57 Europe Toxicology Testing Market Outlook, By Method (2023-2034) ($MN)
  • Table 58 Europe Toxicology Testing Market Outlook, By Biochemical Testing (2023-2034) ($MN)
  • Table 59 Europe Toxicology Testing Market Outlook, By Hematology Testing (2023-2034) ($MN)
  • Table 60 Europe Toxicology Testing Market Outlook, By Pathology Testing (2023-2034) ($MN)
  • Table 61 Europe Toxicology Testing Market Outlook, By Technology (2023-2034) ($MN)
  • Table 62 Europe Toxicology Testing Market Outlook, By In-vivo Testing (2023-2034) ($MN)
  • Table 63 Europe Toxicology Testing Market Outlook, By In-vitro Testing (2023-2034) ($MN)
  • Table 64 Europe Toxicology Testing Market Outlook, By End User (2023-2034) ($MN)
  • Table 65 Europe Toxicology Testing Market Outlook, By Food and Beverage Industry (2023-2034) ($MN)
  • Table 66 Europe Toxicology Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2023-2034) ($MN)
  • Table 67 Europe Toxicology Testing Market Outlook, By Cosmetics and Personal Care Industry (2023-2034) ($MN)
  • Table 68 Europe Toxicology Testing Market Outlook, By Academic and Research Institutions (2023-2034) ($MN)
  • Table 69 Europe Toxicology Testing Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 70 Asia Pacific Toxicology Testing Market Outlook, By Country (2023-2034) ($MN)
  • Table 71 Asia Pacific Toxicology Testing Market Outlook, By Product (2023-2034) ($MN)
  • Table 72 Asia Pacific Toxicology Testing Market Outlook, By Instruments (2023-2034) ($MN)
  • Table 73 Asia Pacific Toxicology Testing Market Outlook, By Reagents and Kits (2023-2034) ($MN)
  • Table 74 Asia Pacific Toxicology Testing Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 75 Asia Pacific Toxicology Testing Market Outlook, By Test Type (2023-2034) ($MN)
  • Table 76 Asia Pacific Toxicology Testing Market Outlook, By Genetic Toxicology Testing (2023-2034) ($MN)
  • Table 77 Asia Pacific Toxicology Testing Market Outlook, By Carcinogenicity Testing (2023-2034) ($MN)
  • Table 78 Asia Pacific Toxicology Testing Market Outlook, By Developmental and Reproductive Toxicology Testing (2023-2034) ($MN)
  • Table 79 Asia Pacific Toxicology Testing Market Outlook, By Other Test Types (2023-2034) ($MN)
  • Table 80 Asia Pacific Toxicology Testing Market Outlook, By Method (2023-2034) ($MN)
  • Table 81 Asia Pacific Toxicology Testing Market Outlook, By Biochemical Testing (2023-2034) ($MN)
  • Table 82 Asia Pacific Toxicology Testing Market Outlook, By Hematology Testing (2023-2034) ($MN)
  • Table 83 Asia Pacific Toxicology Testing Market Outlook, By Pathology Testing (2023-2034) ($MN)
  • Table 84 Asia Pacific Toxicology Testing Market Outlook, By Technology (2023-2034) ($MN)
  • Table 85 Asia Pacific Toxicology Testing Market Outlook, By In-vivo Testing (2023-2034) ($MN)
  • Table 86 Asia Pacific Toxicology Testing Market Outlook, By In-vitro Testing (2023-2034) ($MN)
  • Table 87 Asia Pacific Toxicology Testing Market Outlook, By End User (2023-2034) ($MN)
  • Table 88 Asia Pacific Toxicology Testing Market Outlook, By Food and Beverage Industry (2023-2034) ($MN)
  • Table 89 Asia Pacific Toxicology Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2023-2034) ($MN)
  • Table 90 Asia Pacific Toxicology Testing Market Outlook, By Cosmetics and Personal Care Industry (2023-2034) ($MN)
  • Table 91 Asia Pacific Toxicology Testing Market Outlook, By Academic and Research Institutions (2023-2034) ($MN)
  • Table 92 Asia Pacific Toxicology Testing Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 93 South America Toxicology Testing Market Outlook, By Country (2023-2034) ($MN)
  • Table 94 South America Toxicology Testing Market Outlook, By Product (2023-2034) ($MN)
  • Table 95 South America Toxicology Testing Market Outlook, By Instruments (2023-2034) ($MN)
  • Table 96 South America Toxicology Testing Market Outlook, By Reagents and Kits (2023-2034) ($MN)
  • Table 97 South America Toxicology Testing Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 98 South America Toxicology Testing Market Outlook, By Test Type (2023-2034) ($MN)
  • Table 99 South America Toxicology Testing Market Outlook, By Genetic Toxicology Testing (2023-2034) ($MN)
  • Table 100 South America Toxicology Testing Market Outlook, By Carcinogenicity Testing (2023-2034) ($MN)
  • Table 101 South America Toxicology Testing Market Outlook, By Developmental and Reproductive Toxicology Testing (2023-2034) ($MN)
  • Table 102 South America Toxicology Testing Market Outlook, By Other Test Types (2023-2034) ($MN)
  • Table 103 South America Toxicology Testing Market Outlook, By Method (2023-2034) ($MN)
  • Table 104 South America Toxicology Testing Market Outlook, By Biochemical Testing (2023-2034) ($MN)
  • Table 105 South America Toxicology Testing Market Outlook, By Hematology Testing (2023-2034) ($MN)
  • Table 106 South America Toxicology Testing Market Outlook, By Pathology Testing (2023-2034) ($MN)
  • Table 107 South America Toxicology Testing Market Outlook, By Technology (2023-2034) ($MN)
  • Table 108 South America Toxicology Testing Market Outlook, By In-vivo Testing (2023-2034) ($MN)
  • Table 109 South America Toxicology Testing Market Outlook, By In-vitro Testing (2023-2034) ($MN)
  • Table 110 South America Toxicology Testing Market Outlook, By End User (2023-2034) ($MN)
  • Table 111 South America Toxicology Testing Market Outlook, By Food and Beverage Industry (2023-2034) ($MN)
  • Table 112 South America Toxicology Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2023-2034) ($MN)
  • Table 113 South America Toxicology Testing Market Outlook, By Cosmetics and Personal Care Industry (2023-2034) ($MN)
  • Table 114 South America Toxicology Testing Market Outlook, By Academic and Research Institutions (2023-2034) ($MN)
  • Table 115 South America Toxicology Testing Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 116 Middle East & Africa Toxicology Testing Market Outlook, By Country (2023-2034) ($MN)
  • Table 117 Middle East & Africa Toxicology Testing Market Outlook, By Product (2023-2034) ($MN)
  • Table 118 Middle East & Africa Toxicology Testing Market Outlook, By Instruments (2023-2034) ($MN)
  • Table 119 Middle East & Africa Toxicology Testing Market Outlook, By Reagents and Kits (2023-2034) ($MN)
  • Table 120 Middle East & Africa Toxicology Testing Market Outlook, By Other Products (2023-2034) ($MN)
  • Table 121 Middle East & Africa Toxicology Testing Market Outlook, By Test Type (2023-2034) ($MN)
  • Table 122 Middle East & Africa Toxicology Testing Market Outlook, By Genetic Toxicology Testing (2023-2034) ($MN)
  • Table 123 Middle East & Africa Toxicology Testing Market Outlook, By Carcinogenicity Testing (2023-2034) ($MN)
  • Table 124 Middle East & Africa Toxicology Testing Market Outlook, By Developmental and Reproductive Toxicology Testing (2023-2034) ($MN)
  • Table 125 Middle East & Africa Toxicology Testing Market Outlook, By Other Test Types (2023-2034) ($MN)
  • Table 126 Middle East & Africa Toxicology Testing Market Outlook, By Method (2023-2034) ($MN)
  • Table 127 Middle East & Africa Toxicology Testing Market Outlook, By Biochemical Testing (2023-2034) ($MN)
  • Table 128 Middle East & Africa Toxicology Testing Market Outlook, By Hematology Testing (2023-2034) ($MN)
  • Table 129 Middle East & Africa Toxicology Testing Market Outlook, By Pathology Testing (2023-2034) ($MN)
  • Table 130 Middle East & Africa Toxicology Testing Market Outlook, By Technology (2023-2034) ($MN)
  • Table 131 Middle East & Africa Toxicology Testing Market Outlook, By In-vivo Testing (2023-2034) ($MN)
  • Table 132 Middle East & Africa Toxicology Testing Market Outlook, By In-vitro Testing (2023-2034) ($MN)
  • Table 133 Middle East & Africa Toxicology Testing Market Outlook, By End User (2023-2034) ($MN)
  • Table 134 Middle East & Africa Toxicology Testing Market Outlook, By Food and Beverage Industry (2023-2034) ($MN)
  • Table 135 Middle East & Africa Toxicology Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2023-2034) ($MN)
  • Table 136 Middle East & Africa Toxicology Testing Market Outlook, By Cosmetics and Personal Care Industry (2023-2034) ($MN)
  • Table 137 Middle East & Africa Toxicology Testing Market Outlook, By Academic and Research Institutions (2023-2034) ($MN)
  • Table 138 Middle East & Africa Toxicology Testing Market Outlook, By Other End Users (2023-2034) ($MN)